[1]师 瑜,杨明珠,张娇蕊,等.传染性单核细胞增多症合并多种病原体感染患儿临床特征和预后研究*[J].陕西医学杂志,2020,49(11):1453-1456.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.021]
　SHI Yu,YANG Mingzhu,ZHANG Jiaorui,et al.Clinical features and prognosis of children with infectious mononucleosis complicated by multiple pathogen infections[J].,2020,49(11):1453-1456.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.021]
点击复制

传染性单核细胞增多症合并多种病原体感染患儿临床特征和预后研究*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年11期
页码:
1453-1456
栏目:
临床研究
出版日期:
2020-11-05

文章信息/Info

Title:
Clinical features and prognosis of children with infectious mononucleosis complicated by multiple pathogen infections
作者:
师 瑜; 杨明珠; 张娇蕊; 韩改琳△
陕西省咸阳市中心医院小儿内科(咸阳712000)
Author(s):
SHI Yu; YANG Mingzhu; ZHANG Jiaorui; et al.
Department of Pediatric Medicine,Xianyang Central Hospital,Shaanxi Province(Xianyang 712000)
关键词:
传染性单核细胞增多症;  病原体感染;  临床特征;  预后;  EB病毒;  肺炎支原体
Keywords:
Infectious mononucleosis;  Pathogen infection;  Clinical feature;  Prognosis;  Epstein-barr virus;  Mycoplasma pneumoniae
分类号:
R725.1
DOI:
DOI:10.3969/j.issn.1000-7377.2020.11.021
文献标志码:
A
摘要:
目的:研究传染性单核细胞增多症(IM)合并多种病原体感染患儿的临床特征和预后。方法:纳入IM患儿60例,根据病原体感染情况分为单纯EBV感染组和多重感染组,各30例。分析多重感染组病原体分布特征,比较两组的临床特征、实验室指标、并发症发生率、治疗方法以及预后。结果:IM患儿合并感染病原体主要为肺炎支原体(MP)(33.33%)和巨细胞病毒(CMV)(23.33%)。多重感染组发热、脾脏肿大、肝肿大、淋巴结肿大、咽峡炎、眼睑水肿的发生率明显高于单纯EBV感染组(P<0.05),多重感染组的发热持续时间明显高于单纯EBV感染组(P<0.05)。多重感染组白细胞计数(WBC)、异型淋巴细胞(AL)比例、磷酸肌酶同工酶(CK-MB)、丙氨酸氨基转移酶(ALT)和CD3+水平均明显高于单纯EBV感染组(P<0.05)。多重感染组肺炎、贫血、心肌损害、肝损伤和消化道出血的发生率均明显高于单纯EBV感染组(P<0.05)。两组患儿出院时体温均恢复正常,临床体征均得以明显缓解,心肌功能和肝功能均于治疗2～4周后恢复正常,预后良好。结论:IM患儿的病原体分布特征具有多样性,并以EBV与MP、CMV的多重感染为主。与单纯EBV感染患儿相比,IM多重感染患儿病情更为严重,并发症发生率更高。
Abstract:
Objective:To study the clinical characteristics and prognosis of children with infectious mononucleosis(IM)complicated by multiple pathogen infections.Methods:Sixty children with IM were included and divided into simple EBV infection group and multiple infection group according to pathogen infection,with 30 cases in each group.The distribution characteristics of pathogens in the multiple infection group were analyzed.The clinical characteristics,laboratory indicators,incidence of complications,treatment methods and prognosis of the two groups were compared.Results:The main co-infected pathogens in children with IM were Mycoplasma pneumonia(MP)(33.33%)and Cytomegalovirus(CMV)(23.33%).The incidence of fever,splenomegaly,hepatomegaly,lymphadenopathy,angina and eyelid edema in the multiple infection group was significantly higher than that of simple EBV infection group(P<0.05),and the duration of fever was significantly lower than that of simple EBV infection group(P<0.05).The WBC,AL ratio,CK-MB,ALT and CD3+ levels in the multiple infection group were significantly higher than those in the simple EBV infection group(P<0.05).The incidence of pneumonia,anemia,myocardial damage,liver damage and gastrointestinal bleeding in the multiple infection group was significantly higher than that in the simple EBV infection group(P<0.05).When the two groups of children were discharged from the hospital,their body temperature returned to normal,and their clinical signs were significantly relieved.Myocardial and liver functions returned to normal after 2-4 weeks of treatment,and the prognosis was good.Conclusion:The distribution characteristics of pathogens in children with IM are diverse,and the multiple infections of EBV,MP and CMV are the main ones.Compared with children with simple EBV infection,the condition of IM children with multiple infections are more severe and have a higher incidence of complications.

参考文献/References:

[1] 罗志春,何德根,张 琳,等.加味竹叶石膏汤治疗小儿传染性单核细胞增多症50例[J].陕西中医,2017,38(6):776-777.
[2] 刘雪萍,王爱兰,李佳静.EB病毒感染性儿童传染性单核细胞增多症80例临床分析[J].陕西医学杂志,2016,45(5):532-533.
[3] 周高枫,张锐沐,李 迟,等.阿昔洛韦治疗传染性单核细胞增多症对发热及住院时间的影响[J].儿科药学杂志,2018,24(2):15-17.
[4] 程波利,刘崇海,许玉霞,等.重组人干扰素α-1b治疗儿童传染性单核细胞增多症的疗效评价[J].重庆医学,2018,47(15):2083-2084,2087.
[5] 黄 璐.EB病毒感染儿童的临床特征与实验室检查结果分析[J].中国医学创新,2020,17(15):148-152.
[6] 夏 忆,高 钰,张 庆,等.EB病毒合并多种病原体感染所致传染性单核细胞增多症的临床研究[J].中国小儿血液与肿瘤杂志,2018,23(3):143-147.
[7] 朱未未,周丽娜,蓝秋晔,等.感染传染性单核细胞增多症患儿的临床特征与护理[J].中华医院感染学杂志,2017,27(23):5480-5483.
[8] 曾 文,麦荣嘉,何秋苑,等.HCMV和MP感染所致儿童传染性单核细胞综合征的临床特征[J].中国妇幼保健,2018,33(12):2732-2735.
[9] 董改琴,吕 翔,陈敏华.82例儿童传染性单核细胞增多症临床分析[J].中国医科大学学报,2017,46(12):1147-1149.
[10] 吴 洁.儿童传染性单核细胞增多症的临床特征及并发肝损害的相关因素分析[D].天津:天津医科大学,2017.
[11] 洪淑君,潘 静,倪文泉,等.巨细胞病毒致儿童传染性单核细胞增多综合征81例临床分析[J].中华全科医学,2016,14(10):1686-1688,725.
[12] 汪东海,陈建川,田代印,等.儿童EB病毒致传染性单核细胞增多症并肺炎的危险因素[J].中华实用儿科临床杂志,2019,10(22):1698-1701.
[13] 刘瑞海,李 晶,曲妮燕,等.4例EB病毒感染相关急性肝功能衰竭患儿的临床特点分析[J].中国当代儿科杂志,2018,20(12):1030-1033.
[14] 欧阳文献,朱咏贵,李双杰,等.儿童传染性单核细胞增多症临床特征及治疗的单中心研究[J].中华实验和临床病毒学杂志,2018,32(1):12-16.
[15] 马忠玉,孙 莉,张晓军.重组人干扰素α-1b联合更昔洛韦治疗小儿传染性单核细胞增生症疗效及对患儿免疫力影响分析[J].陕西医学杂志,2018,47(10):1334-1336.

相似文献/References:

[1]韩冬梅,乐 原.传染性单核细胞增多症患儿EB病毒DNA载量与免疫指标及白细胞计数和血沉水平相关性分析[J].陕西医学杂志,2022,51(7):882.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.028]
[2]马永梅,樊 荣.传染性单核细胞增多症患儿血清Toll样受体2、Toll样受体9与外周血T淋巴细胞亚群变化及临床意义[J].陕西医学杂志,2022,51(11):1416.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.023]
　MA Yongmei,FAN Rong.Changes and clinical significance of serum TLR2,TLR9 and peripheral blood T lymphocyte subsets in children with infectious mononucleosis[J].,2022,51(11):1416.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.023]

备注/Memo

备注/Memo:
*陕西省重点研发计划项目(2019SF-045)
更新日期/Last Update: 2020-11-05